8-K ·Filed Apr 27, 2026

HCA

HCA Healthcare, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001193125-26-182265
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor pricing of the new senior notes; a successful refinancing at favorable rates would modestly reduce interest costs. The transaction is routine and not expected to materially impact equity valuation.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
HCA ▼ -12.74% at T+60d
NEUTRAL call ✗ call lost -12.74% · α vs SPY -16.46% · entry $431.48 → $376.50
Entry anchored
Apr 27, 03:59 PM ET
via exchange tick
T+1d
+0.61%
call +0.61% · α +0.62%
$434.14
settled 5mo ago
T+5d
-1.00%
call -1.00% · α -2.69%
$427.18
settled 5mo ago
T+20d
-9.05%
call -9.05% · α -14.52%
$392.42
settled 4mo ago
T+60d
-12.74%
call -12.74% · α -16.46%
$376.50
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

HCA Healthcare subsidiary HCA Inc. announced a proposed public offering of senior notes (terms TBD) to refinance $2.5B in maturing notes due June and September 2026, and to repay commercial paper borrowings. The redemption of the existing notes is conditioned on the offering's closing, expected by May 27, 2026.

Key Facts

  • HCA Inc. proposes offering senior notes; terms depend on market conditions
  • Plans to redeem $1.500B of 5.250% notes due June 2026 and $1.000B of 5.375% notes due September 2026
  • Redemption conditioned on receipt of net proceeds from the offering
  • Net proceeds also may repay borrowings under $4.000B commercial paper program
  • Redemption date: May 27, 2026

Financial Impact

Refinancing of $2.5B in near-term debt; potential interest expense savings if new notes priced lower

debtinterest expense

Risk Factors

  • If offering fails, redemption may not occur, but HCA can likely refinance via other means
  • Interest rate volatility could affect terms of new notes

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
58% bullish (31 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-182265
Document: hca-ex99_1.htm0001193125-26-182265
Document: 0001193125-26-182265-index-headers.html0001193125-26-182265
Document: 0001193125-26-182265-index.html0001193125-26-182265
Document: 0001193125-26-182265.txt0001193125-26-182265
8 reports for HCA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HCA — sortable, filterable
TypeNow
Jul 24, 2026
10w ago
8-K
MIXED ★ 5/10
$382.19 $429.19▲ +12.30%▲ +8.67%$426.69 (+11.64%)
Jul 14, 2026
11w ago
8-K
BEARISH ★ 6/10
$363.60 $411.44▼ −13.16%▼ −10.67%$426.69 (−17.35%)
Jun 18, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$375.17 $385.74▲ +2.82%▲ +2.28%$426.69 (+13.73%)
Apr 27, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$431.48 $392.42▼ −9.05%▼ −14.52%$426.69 (−1.11%)
Apr 27, 2026
22w ago
Court Ruling
NEUTRAL ★ 1/10
$445.70 $392.48▼ −11.94%▼ −16.87%$426.69 (−4.26%)
Apr 24, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$432.55 $392.56▼ −9.25%▼ −13.27%$426.69 (−1.36%)
Mar 13, 2026
29w ago
DEFA14A
NEUTRAL ★ 3/10
$525.04 $496.74▼ −5.39%▼ −9.17%$426.69 (−18.73%)
Feb 25, 2026
31w ago
8-K
NEUTRAL ★ 3/10
$525.78 $479.78▼ −8.75%▼ −2.35%$426.69 (−18.85%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access